Congress Summaries Authored by the Vanguard Committee

→2023 Annual Congress summary

→2022 Annual Congress summary

→ 2021 Annual Congress summary

→2019 Annual Congress summary

→2018 Annual Congress summary

→2016 Annual Congress summary

Vanguard Debate Sessions

→2023

• Contraindications to Liver Transplantation: Hepatologist vs Anesthesiologist View

• Hepatologist View
• Anesthesiologist View

• Liver Transplantation for Liver Failure after Hepatectomy: Yes or No

• Yes
• No

• Post-Transplant Monitoring for Alcohol Recidivism: Yes or No

→2022

→2021

→2019

• • Transplant Center Performance is Adequately/Not Adequately represented in 1 year Graft and Patient Survival
    • Adequately represented
    • Not Adequately represented
  • SLK vs Sequential Transplant
    • SLK argument
    • Sequential argument 

→ 2018

• • Who should receive marginal quality liver?
    • Who should receive a marginal quality liver: the low MELD or the high MELD patient? Eleanora De Martin
    • Who should receive a marginal quality liver: the low MELD or the high MELD patient? Kelvin KC Ng
  • Bigger is better: High Volume vs Low Volume Centers
    • Bigger is Better: Fewer high volume centers serve populations better than multiple low volume centers. Carmen Vinaixa
    • Bigger is Better: Fewer high volume centers serve populations better than multiple low volume centers. Irene Scalera 
  • ECMO as Bridge to Liver Transplantation
    • ECMO as a Bridge to OLT (Other than in Hepatopulmonary Syndrome) – Pro/Con. Ryan Chadha
    • ECMO as a Bridge to OLT (Other than in Hepatopulmonary Syndrome) – Pro/Con. Michael Kaufman 

Vanguard Symposium

→2023 Vanguard and Pediatric Committee Symposium

• Cardiometabolic Outcomes Following Liver Transplantation
• Multi-organ Transplantation Outcomes: Is It Worth It
• Expanding Outcome Metrics: Benchmarking in Pediatric Liver Transplantation

→2022 Special Session on ERAS

→2022 Frailty in Liver Transplantation: Is it a Real Challenge

→2021 ACLF

→2019 Portal Vein Thrombosis

• • Pre transplant evaluation and management of a patient with diffuse PVT on the waiting list: staging, medical management, anticoagulation
  • Converting untransplantable patients with chronic obliterative PVT and cavernoma to transplantability using trans-splenic portal vein recanalization TIPS
  • Outcomes of LT in a recipient with diffuse PVT: True survival benefit and implications for organ allocation
  • Multivisceral Transplantation for Diffuse Splanchnic Thrombosis
  • Outcomes of LT in a recipient with Diffuse PVT: True Survival benefit and implications for organ allocation.

Vanguard Surgical Video Session

→2023

Different Forms of Surgical Bypasses

Zero Cold Ischemia Liver Transplantation

Peripheral Nerve Blocks for Post LT Analgesia

→2022 

→2021

→2018

• • Procurement technique for abdominal multivisceral transplant
  • Technique for split liver– in situ and bench split
  • Right lobe LDLT implantation technique

Vanguard Case Presentations

→2023

• Portal Overflow after Left Renal Ligation in the Setting of Large Splenorenal Shunt
• Immunotherapy as a Neoadjuvant Therapy for Patients with HCC in Pre-transplant Setting
• Stem Cell Transplantation as a Successful Salvage Treatment of Recurrent Primary Sclerosing Cholangitis after Three Transplants

→2022

→2021

→2018

• • Recurrent portal vein thrombosis after liver transplantation for Budd-Chiari syndrome despite aggressive anticoagulation treatment. Splanchnic Venous Thrombosis
  •  Cholangiopathy: Insight from Explant Liver Graft from a Child with Severe Post Operative Hypoxemia due to Hepatopulmonary Syndrome
  • Systolic Anterior Motion of Mitral Valve after Reperfusion in Liver Transplantation